| 发明名称 |
MGLU2/3 ANTAGONISTS FOR THE TREATMENT OF INTELLECTUAL DISABILITIES |
| 摘要 |
The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of intellectual disabilities. In another aspect, the invention relates to a pharmaceutical composition for use in the treatment of intellectual disabilities comprising a compound according to the invention and a pharmaceutically acceptable carrier. |
| 申请公布号 |
US2017035767(A1) |
申请公布日期 |
2017.02.09 |
| 申请号 |
US201615331466 |
申请日期 |
2016.10.21 |
| 申请人 |
Hoffmann-La Roche Inc. |
发明人 |
Ballard Theresa M.;McArthur Silvia Gatti;Saxe Michael;Wichmann Juergen;Woltering Thomas |
| 分类号 |
A61K31/519;A61K31/444 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A mGlu2/3 negative allosteric modulator for use in the treatment, and/or prevention of intellectual disabilities. |
| 地址 |
Little Falls NJ US |
